Amd §207, Pub Health L (as proposed in S.8965-A & A.6799-B)
Provides for education and outreach for drug-induced movement disorders by the department of health through the health care and wellness education and outreach program.
NEW YORK STATE ASSEMBLY MEMORANDUM IN SUPPORT OF LEGISLATION submitted in accordance with Assembly Rule III, Sec 1(f)
BILL NUMBER: A1017
SPONSOR: Paulin TITLE OF BILL:
An act to amend the public health law, in relation to authorizing the
health care and wellness education and outreach program to develop and
disseminate information regarding drug-induced movement disorders
PURPOSE:
To make changes to the requirements on provided information related to
telehealth and reducing stigma for people living with drug induced move-
ment disorders.
SUMMARY OF PROVISIONS:
This bill would clarify that information regarding drug-induced movement
disorders will be developed by the Department of Health in consultation
with the Office of Mental Health and disseminated by the Department of
Health.
JUSTIFICATION:
Patients receiving treatment with medications for their mental health
conditions may be at risk of developing a drug-induced movement disorder
These involuntary movement disorders are caused by medications that help
control dopamine, such as first- and second-generation antipsychotics
commonly prescribed to treat people living with mental illnesses. Some
drug-induced movement disorders, such as tardivedyskinesia; are persist-
ent, irreversible- potentially disabling neurological conditions charac-
terized by uncontrollable repetitive movements of the face, torso, or
other parts of the body. While untreated involuntary movements can be
stigmatizing and debilitating, the rates of undiagnosed patients living
with drug-induced movement disorders remains high.
LEGISLATIVE HISTORY:
This is a new bill.
BUDGET IMPLICATIONS: None noted.
EFFECTIVE DATE:
This act shall take effect on the same date and in the same manner as a
chapter of the laws of 2024 amending the public health law relating to
establishing a drug-induced movement disorder screening education
program, as proposed in legislative bills numbers S. 8965-A 8 and A.
6799-B, takes effect
STATE OF NEW YORK
________________________________________________________________________
1017
2025-2026 Regular Sessions
IN ASSEMBLY(Prefiled)
January 8, 2025
___________
Introduced by M. of A. PAULIN -- read once and referred to the Committee
on Health
AN ACT to amend the public health law, in relation to authorizing the
health care and wellness education and outreach program to develop and
disseminate information regarding drug-induced movement disorders
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Paragraph (h) of subdivision 1 of section 207 of the public
2 health law, as added by a chapter of the laws of 2024 amending the
3 public health law relating to establishing a drug-induced movement
4 disorder screening education program, as proposed in legislative bills
5 numbers S. 8965-A and A. 6799-B, is amended to read as follows:
6 (h) [The department shall develop and conduct a program concerning
7 drug-induced] Drug-induced movement disorders[. Such program shall
8 include but not be limited to, (i) educational information on], includ-
9 ing the importance of screening for and identifying symptoms of drug-in-
10 duced movement disorders[; and (ii) the development and dissemination of
11 educational materials for healthcare providers regarding], treatment for
12 drug-induced movement disorders, [including for services provided via
13 telehealth. Such] and information on methods by which the stigma expe-
14 rienced by people living with drug-induced movement disorders related to
15 the treatment of mental health conditions may be reduced or eliminated.
16 Any such educational materials disseminated to healthcare providers
17 shall be developed [and] in consultation with the commissioner of the
18 office of mental health, disseminated by the department in coordination
19 with relevant healthcare provider groups, and shall include best prac-
20 tices for the treatment and screening of movement disorders informed by
21 the American Psychiatric Association and other professional society
22 practice guidelines. [Such program shall also include education and
23 outreach on the elimination of stigma for people living with drug-in-
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD02693-01-5
A. 1017 2
1 duced movement disorders related to the treatment of mental health
2 conditions.]
3 § 2. This act shall take effect on the same date and in the same
4 manner as a chapter of the laws of 2024 amending the public health law
5 relating to establishing a drug-induced movement disorder screening
6 education program, as proposed in legislative bills numbers S. 8965-A
7 and A. 6799-B, takes effect.
